Biogen Idec (BIIB) said two new dosing innovations designed to help patients receiving once-a-week AVONEX for relapsing forms of multiple sclerosis, or MS, are now available in U.S. pharmacies.
The new AVONEX PEN is the first intramuscular autoinjector for chronic use, designed to enhance the self-injection process for patients receiving AVONEX therapy. The company noted that a new dose titration regimen, facilitated by the AVOSTARTGRIP titration devices, provides patients with the option to gradually increase the dose of AVONEX at treatment initiation to reduce the incidence and severity of flu-like symptoms that patients may experience with therapy.
These product enhancements offer the potential for a more tolerable initiation and an easier injection process compared to the AVONEX Prefilled Syringe.
AVONEX PEN is available from the same pharmacies patients currently fill their AVONEX Prefilled Syringe prescriptions.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.